We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.26B
AUM Growth
-$991M
(-12%)
Cap. Flow
-$861M
Cap. Flow
% of AUM
-11.85%
Top 10 Holdings %
Top 10 Hldgs %
17.28%
Holding
1,731
New
11
Increased
301
Reduced
1,277
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$11.7M |
| 2 |
Archer Daniels Midland
ADM
|
+$11.3M |
| 3 |
Nucor
NUE
|
+$10.5M |
| 4 |
Dover
DOV
|
+$10.2M |
| 5 |
Brown-Forman Class B
BF.B
|
+$9.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$49.6M |
| 2 |
Microsoft
MSFT
|
+$36.8M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$30.3M |
| 4 |
Gilead Sciences
GILD
|
+$23.6M |
| 5 |
Amgen
AMGN
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.22% |
| 2 | Technology | 14.93% |
| 3 | Financials | 13.79% |
| 4 | Consumer Staples | 9.84% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1526
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $91K | ﹤0.01% |
16,983
-1,777
| -9% | -$11.2K |
|
|
AEGR
1527
DELISTED
Aegerion Pharmaceuticals
AEGR
| $90K | ﹤0.01% |
24,329
-2,594
| -10% | -$16.1K |
|
|
CCXI
1528
DELISTED
ChemoCentryx, Inc.
CCXI
| $89K | ﹤0.01% |
35,848
-3,714
| -9% | -$13.5K |
|
|
CDR
1529
DELISTED
Cedar Realty Trust, Inc
CDR
| $88K | ﹤0.01% |
1,836
-321
| -15% | -$14.7K |
|
1530
Helix Energy Solutions
HLX
$1.46B
| $85K | ﹤0.01% |
15,256
-2,611
| -15% | -$11K |
|
|
TRST
1531
Trustco Bank Corp NY
TRST
$1B
| $84K | ﹤0.01% |
2,764
-476
| -15% | -$13.6K |
|
1532
Lattice Semiconductor
LSCC
$17.6B
| $81K | ﹤0.01% |
14,298
-2,705
| -16% | -$14.6K |
|
|
EXAS
1533
DELISTED
Exact Sciences
EXAS
| $79K | ﹤0.01% |
11,740
-2,223
| -16% | -$14.2K |
|
1534
Arcturus Therapeutics
ARCT
$157M
| $76K | ﹤0.01% |
2,872
-271
| -9% | -$9.18K |
|
1535
Amkor Technology
AMKR
$16.1B
| $75K | ﹤0.01% |
12,783
-1,617
| -11% | -$8.78K |
|
1536
TETRA Technologies
TTI
$1.23B
| $74K | ﹤0.01% |
11,586
-1,999
| -15% | -$11.7K |
|
1537
Viavi Solutions
VIAV
$9.75B
| $72K | ﹤0.01% |
10,561
-1,959
| -16% | -$11.8K |
|
|
PIR
1538
DELISTED
Pier 1 Imports, Inc.
PIR
| $72K | ﹤0.01% |
512
-144
| -22% | -$14.7K |
|
|
ELNK
1539
DELISTED
EarthLink Holdings Corp.
ELNK
| $72K | ﹤0.01% |
12,619
-2,389
| -16% | -$13.9K |
|
|
ATYR
1540
aTyr Pharma
ATYR
$46.4M
| $71K | ﹤0.01% |
1,294
-127
| -9% | -$9.65K |
|
1541
Enviri
NVRI
$621M
| $67K | ﹤0.01% |
12,205
-8,805
| -42% | -$50.8K |
|
|
OREX
1542
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $67K | ﹤0.01% |
11,948
-1,238
| -9% | -$16.1K |
|
|
AHT
1543
Ashford Hospitality Trust
AHT
$21M
| $65K | ﹤0.01% |
10
-2
| -17% | -$10.8K |
|
1544
DHT Holdings
DHT
$2.97B
| $65K | ﹤0.01% |
11,367
-2,151
| -16% | -$12.8K |
|
|
OCLR
1545
DELISTED
Oclaro Inc.
OCLR
| $65K | ﹤0.01% |
11,970
-2,264
| -16% | -$9.56K |
|
1546
Cleveland-Cliffs
CLF
$6.81B
| $64K | ﹤0.01% |
21,381
-23,444
| -52% | -$49.1K |
|
|
ADAM
1547
Adamas Trust
ADAM
$777M
| $63K | ﹤0.01% |
3,347
-633
| -16% | -$11.9K |
|
1548
First Bancorp
FBP
$4.4B
| $59K | ﹤0.01% |
20,241
-3,506
| -15% | -$9.34K |
|
|
KERX
1549
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $59K | ﹤0.01% |
12,682
-2,399
| -16% | -$9.57K |
|
|
CRC
1550
DELISTED
California Resources Corporation
CRC
| $58K | ﹤0.01% |
5,599
-5,286
| -49% | -$62.4K |
|
Similar funds
ProShare Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, ProShare Advisors held 1,731 positions worth $7.26B, down 12% from $8.26B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ProShare Advisors withdrew a net $861M in Q1 2016, closing 139 positions and reducing 1,277 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, ProShare Advisors opened a new position in ProShares Managed Futures Strategy ETF worth $5.35M.
- ProShare Advisors's largest Q1 2016 buy was ProShares Managed Futures Strategy ETF: 134,581 shares worth $5.35M.
- ProShare Advisors added most to Pentair in Q1 2016, an estimated $11.7M increase.
- ProShare Advisors's biggest Q1 2016 reduction was Apple, cutting an estimated $49.6M.
- ProShare Advisors fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $30.3M.
- ProShare Advisors's ten largest holdings make up 17% of its $7.26B portfolio in Q1 2016.
- ProShare Advisors opened 11 new positions and closed 139 in Q1 2016.
- ProShare Advisors's portfolio value fell 12% quarter-over-quarter to $7.26B.
Based on ProShare Advisors's 13F filing for Q1 2016, filed 6 May 2016.